Source:http://linkedlifedata.com/resource/pubmed/id/20176206
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2010-2-23
|
pubmed:abstractText |
Esophageal adenocarcinoma is thought to arise from lesions produced by chronic esophageal inflammation. Secretory phospholipase A(2) is an important mediator of mucosal response to gastroesophageal reflux, but its role in the function of mature cancer cells is unclear. We sought to determine the influence of group IIa secretory phospholipase A(2) on proliferation of human esophageal adenocarcinoma cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1097-685X
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2010 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
139
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
591-9; discussion 599
|
pubmed:meshHeading | |
pubmed:year |
2010
|
pubmed:articleTitle |
Modulation of growth in human esophageal adenocarcinoma cells by group IIa secretory phospholipase A(2).
|
pubmed:affiliation |
Department of Surgery, Division of Cardiothoracic Surgery, University of Colorado Denver School of Medicine, Aurora, CO, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|